Monica Albertson, OD
Optometry · Blue Ash
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Cei Physicians Psc, LLC · 155 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Albertson’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$41,820
Medicare paid this office $41,820 for 420 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 193 | $12,724 | $58 |
| Return visit (30+ min) | 89 | $9,804 | $90 |
| Established patient complete exam of visual system | 57 | $5,013 | $82 |
| New patient visit (30+ min) | 76 | $4,634 | $61 |
| New patient complete exam of visual system | 29 | $2,654 | $92 |
See all 10 services
| Short return visit (20+ min) | 193 | $12,724 | $58 |
| Return visit (30+ min) | 89 | $9,804 | $90 |
| Established patient complete exam of visual system | 57 | $5,013 | $82 |
| New patient visit (30+ min) | 76 | $4,634 | $61 |
| New patient complete exam of visual system | 29 | $2,654 | $92 |
| New patient visit (45+ min) | 18 | $1,971 | $109 |
| Imaging of retina | 65 | $1,961 | $27 |
| Exam of visual field with extended testing | 20 | $1,111 | $46 |
| Exam to measure eye deviation and range of motion | 12 | $612 | $47 |
| Imaging of optic nerve | 20 | $588 | $27 |
Who their Medicare patients are
420 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 15% · Women 57% · Also on Medicaid 7% · Health risk score 1.35. Sicker patients than 9 in 10 peers; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 74% · Diabetes 36% · Coronary heart disease 33% · Chronic kidney disease 23% · Depression 22% · Atrial fibrillation 20% · Heart failure 19% · Cancer 15% · COPD 15% · Stroke 11% · Dementia 6%.
The office billed $252,645, Medicare allowed $60,049 and paid $41,820; for 665 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 420 | 665 | 75 | 1.35 | $252,645 | $41,820 |
| 2023 | 138 | 182 | 74 | 1.23 | $68,444 | $12,287 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 65 | $4,376 | $65 |
| New patient visit (30+ min) | 30 | $2,298 | $77 |
| Return visit (30+ min) | 18 | $1,744 | $97 |
| Established patient complete exam of visual system | 14 | $1,314 | $94 |
| Imaging of retina | 24 | $664 | $28 |
Medicaid work
$777 in 2023
Medicaid paid $777 for 31 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 31 | $777 |
| 2023 | 31 | 1 | 15 | $777 |
Drugs they prescribed that Part D paid
$15,426
Pharmacies billed $15,426 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 253) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
175 generic and 78 brand-name prescriptions · $15,426 in drug cost · 19 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 55 | $1,236 | $22 |
| Moxifloxacin | 21 | $806 | $38 |
| Valacyclovir | 19 | $347 | $18 |
| Latanoprost | 50 | $238 | $5 |
| Dorzolamide-Timolol | 18 | $219 | $12 |
See all 7 drugs
| Prednisolone Acetate | 55 | $1,236 | $22 |
| Moxifloxacin | 21 | $806 | $38 |
| Valacyclovir | 19 | $347 | $18 |
| Latanoprost | 50 | $238 | $5 |
| Dorzolamide-Timolol | 18 | $219 | $12 |
| Erythromycin | 22 | $214 | $10 |
| Timolol Maleate | 12 | $23 | $2 |
Year by year
| 2024 | 253 | 136 | 0% (0) | 31% | $15,426 |
| 2023 | 23 | 22 | 0% (0) | None | $1,797 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$510 in 2025
| 2025 | 7 | 10 | None | $510 |
| 2024 | 5 | 11 | None | $382 |
| 2023 | 5 | 15 | None | $1,665 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tarsus Pharmaceuticals | Xdemvy | $132 | 3 payments
|
| Bausch & Lomb Americas | Infuse | $125 | 1 payment
|
| Alcon Vision | Tryptyr | $106 | 1 payment
|
| CooperVision | Myday Contact Lens | $66 | 2 payments
|
| Regeneron Healthcare Solutions | Eylea Hd | $35 | 1 payment
|
| Dompe US | Oxervate | $23 | 1 payment
|
See all 10 published payments
| Bausch & Lomb Americas | Meals · 2025-10-15 | Infuse | $125 |
| Dompe US | Meals · 2025-09-23 | Oxervate | $23 |
| Alcon Vision | Meals · 2025-09-11 | Tryptyr | $106 |
| Astellas Pharma US | Meals · 2025-08-20 | Izervay | $23 |
| Tarsus Pharmaceuticals | Meals · 2025-05-13 | Xdemvy | $18 |
| Tarsus Pharmaceuticals | Meals · 2025-03-18 | Xdemvy | $97 |
| CooperVision | Meals · 2025-03-14 | Myday Contact Lens | $46 |
| CooperVision | Meals · 2025-03-06 | Myday Contact Lens | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-02-05 | Eylea Hd | $35 |
| Tarsus Pharmaceuticals | Meals · 2025-01-30 | Xdemvy | $17 |
See earlier years (2024, 2023)
2024: $382
| Tarsus Pharmaceuticals | Xdemvy | $165 | 3 payments
|
| Astellas Pharma US | Izervay | $127 | 4 payments
|
| Regeneron Healthcare Solutions | Eylea Hd | $35 | 1 payment
|
| Abbvie | Durysta | $34 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $22 | 1 payment
|
2023: $1,665
| CooperVision | Cvi Contact Lens | $1,404 | 10 payments
|
| Horizon Therapeutics plc | Tepezza | $125 | 1 payment
|
| Alcon Vision | Hydrus Microstent | $68 | 1 payment
|
| Astellas Pharma US | None | $47 | 2 payments
|
| Apellis Pharmaceuticals | Syfovre | $21 | 1 payment
|
Professional record
- NPI
- 1750010674
- Licence
- OH OPT.007042
- Trained
- Ohio State University - College of Optometry, 2022
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 990 Paradrome St, Cincinnati, OH, 45202
- NPI first listed
- 2022-06-07
- NPI last updated
- 2023-07-25
- NPI record certified
- 2023-07-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1945 Cei Dr, Blue Ash, OH, 45242